The largest database of trusted experimental protocols

Bp monitor

Manufactured by Omron

The Omron BP monitor is a device designed to measure and display a person's blood pressure. It is a compact, portable device that can be used in a variety of settings, including home, clinic, or hospital. The monitor uses an inflatable cuff that is wrapped around the arm to measure the systolic and diastolic blood pressure, which are then displayed on the device's screen.

Automatically generated - may contain errors

9 protocols using bp monitor

1

Myanmar Diabetes Prevalence Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Ethical Committee of the Department of Medical Research (Lower Myanmar) approved the current study to conduct verbal informed consent of the participants. The duration of data collection was from September to December, 2014. Participants provided verbal consents after receiving explanation about the study. The trained interviewers collected data relating to sociodemography, health behaviors, anthropometry, and blood pressures (BPs) via face-to-face interviews and physical examinations. Ten-hour overnight fast was requested in advance. Fasting capillary blood samples were tested for plasma glucose (PG) and lipids, and capillary blood samples were tested for glucose 2 hours after glucose load. BP measure was preceded by a resting time of 10 minutes before measurement.
In addition to the questionnaire instrument, survey tools for measurement consisted of a stadiometer for measuring height, a weighing scale, measuring tape for waist and hip measurement, and an Omron BP monitor. The lipid profile, fasting plasma glucose (FPG), and 2 hours PG were determined on-site using a portable LipidoCare device. Preliminary data were allowed to republish by authors of presentation, Latt TS et al, and with the permission of the president of Myanmar Diabetes Association.15
+ Open protocol
+ Expand
2

Anthropometric and Blood Pressure Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anthropometric measurements were obtained by trained investigators using standard techniques. Weight and height were recorded to the nearest 0.1 kg and 0.1 cm, respectively, to calculate BMI. Waist was measured in centimeters (cm) at the narrowest circumference halfway between the lowest rib and the iliac crest. Systolic BP (SBP) and diastolic BP (DBP) were measured by use of an automatic oscillometric device, Omron BP monitor. Three readings were made with the subjects seated after they had rested for 5 minutes. The average of the second and third readings was used in the analysis [14 ].
+ Open protocol
+ Expand
3

Diabetes Clinical Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data collection took place during diabetes clinics at the outpatient departments. The first author and three research assistants collected the data. During each section, the first author explained to patients the purpose of the study, indicating the inclusion and exclusion criteria. Prospective participants were screened to ensure they were eligible to participate in the study. They were assured of anonymity, confidentiality, and the freedom to participate or withdraw from the study at any time. All participants provided written informed consent.
Testing began by measuring participants’ height. This measure was then entered into an Omron Body Composition Monitor, which was then used to measure their weight and determine their BMI. Blood pressure (BP) levels were then measured using an Omron BP Monitor. The research assistants then proceeded to administer the questionnaires to participants electronically using a Samsung Tablet A. Participants’ blood samples were also taken by finger prick, to test their glycated haemoglobin (HbA1c) using the PTS A1c + kits, which yields results in 5 min. This test was done concurrently with the administration of questionnaires.
+ Open protocol
+ Expand
4

Anthropometric and Blood Pressure Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Demographic details were recorded. Weight was measured in minimum clothing using calibrated scales. Height was measured as per standard protocols using a wall mount height measurement scale. The Body Mass index (BMI) was calculated as kg/m2 and categorised as BMI ≥ 25 kg/m2 and BMI <25 kg/m2. The blood pressure was measured using a validated Omron BP monitor following WHO protocol (38 ). Hypertension was defined as blood pressure ≥ 140/90 mmHg or use of antihypertensive medications. The waist and hip circumferences were measured using standard methods (39 ). Abdominal obesity was defined as waist circumference ≥ 90 cm in men or ≥ 80 cm in women (40 (link)). All these anthropometric measurements, along with blood pressure, was measured three times by a trained study nurse, and the mean of three values was used for analysis.
+ Open protocol
+ Expand
5

Standardized Blood Pressure Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood pressure (BP) was measured in the right arm and in the standard sitting position, using an Omron BP monitor. The measurement was repeated twice after a 15-minute rest. If the 2 values were similar, the first measurement was used. If the 2 values were different, the number of measurement would be increased, and the highest value among comparable results would be selected.
+ Open protocol
+ Expand
6

Orthostatic Hypotension Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The OH status of participants was unknown before this study. No participants were being treated for OH at the time of the study. After the continuous beat‐to‐beat BP recording, participants completed the lying‐to‐standing assessment of OH in the same room following an established protocol (Freeman et al., 2012 (link)). Specifically, participants rested in a lying position for 10 min, and then actively moved to a standing position as quickly as possible. They were then asked to remain motionless for 3 min. The level of their SBP and DBP was measured using a BP monitor (OMRON Healthcare, Inc.) when lying and in standing conditions once each minute. If a maximum reduction of SBP of at least 20 mmHg and/or DBP of 10 mmHg was observed within 3 min of standing as compared to the average BP level in the lying condition, the participant was identified as having OH (Freedman et al., 2011 (link)). The percent change of BP level from lying to standing position was also calculated and used as the outcome measuring the orthostatic change of BP regulation.
+ Open protocol
+ Expand
7

Remote Blood Pressure Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
To accommodate remote data collection, we identified at-home digital BP monitors participants could operate during videoconference research visits. After investigating the available options for a BP monitor that was clinically-validated, affordable, and easy to use, we purchased the Omron® BP7100 digital upper arm monitor for all participants.
Participants were shipped a box of study supplies in advance of their Zoom® enrollment (randomization) visit. Participants received the Omron® BP monitor; 4 AA batteries for the monitor; and a flexible measuring tape to measure arm circumference.
+ Open protocol
+ Expand
8

Automated BP Measurement Procedure

Check if the same lab product or an alternative is used in the 5 most similar protocols
Study visit BP will be measured using the method recommended by the BIHS15 (link) with a validated, automated Omron BP monitor. After 5 minutes rest, 3 BP measurements will be taken, 1 minute apart with the average of the second and third recorded as visit BP.
+ Open protocol
+ Expand
9

Renal Denervation Protocol Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
After admission, the patients rested for approximately 15 minutes. The sitting BP of the patients was measured 3 times using an Omron BP monitor, and the mean of these 3 BP results was calculated. The morning after admission, venous blood was collected to perform examinations such as routine blood tests, blood electrolyte tests, and liver function tests. The levels of serum creatinine were measured using the chemiluminescence method. The GFR was calculated using the MDRD equation or using cystatin C to represent the estimated GFR (eGFR). The simplified modification of diet in the renal disease study equation was: eGFR = 186 × [serum creatinine (μm)/88.4]−1.154 × age−0.203 × (0.742 if female). Further monitoring included 24‐hour urinary protein quantitation, electrocardiography (ECG), ambulatory BP monitoring, echocardiogram, urinary tract ultrasonography, and MSCTA of the renal artery. The BP of patients at 1 week and at 1, 3, 6, and 12 months after RDN were measured through outpatient follow‐up. The serum creatinine levels and 24‐hour urinary protein quantitation of the patients were measured at 1, 3, 6, and 12 months after RDN. Renal color ultrasound was performed again 6 months after RDN, and MSCTA of the renal artery was re‐examined 12 months after RDN.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!